Alfreda Falkowska Grosrenaud
Psychiatry · Chicago, ILNPI 1124000906
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.5% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,526 and has fallen 55.4% since, to $1,573 in 2025. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $33.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- Supernus Pharmaceuticals, Inc.$899
- Tris Pharma Inc$625
- Neos Therapeutics, LP$605
- Corium, LLC$496
- Otsuka America Pharmaceutical, Inc.$402
- plus $3K from 14 others
What the payments were for
- Travel & lodging$66310%
- Food & beverage$6,28290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 2 | $1,410 |
| Supernus Pharmaceuticals, Inc. | 34 | $899 |
| Tris Pharma Inc | 26 | $625 |
| Neos Therapeutics, LP | 14 | $605 |
| Corium, LLC | 19 | $496 |
| Otsuka America Pharmaceutical, Inc. | 17 | $402 |
| AbbVie | 19 | $397 |
| Ironshore Pharmaceuticals Inc. | 12 | $365 |
| Johnson & Johnson | 10 | $309 |
| E.r. Squibb & Sons, L.L.C. | 11 | $304 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $274 |
| Axsome Therapeutics, Inc. | 6 | $229 |
| Lundbeck LLC | 10 | $197 |
| Sunovion Pharmaceuticals Inc. | 1 | $111 |
| Noven Therapeutics, LLC | 6 | $100 |
| Harmony Biosciences LLC | 3 | $87 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Shire North American Group Inc | 2 | $29 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,410
- Adzenys XR-ODT$434
- QELBREE$282
- JORNAY PM$226
- Azstarys$215
- SPRAVATO$125
- COBENFY$120
- Dyanavel XR$119
- Auvelity$113
- Cotempla XR-ODT$112
- Karbinal$112
- LATUDA$111
How this compares
$6,946 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Chicago
- Mitchell GlaserChicago$752K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Jeffrey RadoChicago$208K
- K Ranga KrishnanChicago$92K
- Richard BaerChicago$44K
- Adam GoldenbergChicago$23K
- Olusola AjiloreChicago$21K
- Emil CoccaroChicago$20K
- Guarava AgarwalChicago$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.